APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $360,237,925 | -57.9% | 9,469,977 | +0.7% | 0.01% | -55.0% |
| Q2 2023 | $856,457,519 | +36.3% | 9,401,290 | -1.3% | 0.02% | +25.0% |
| Q1 2023 | $628,529,146 | +31.9% | 9,528,944 | +3.4% | 0.02% | +23.1% |
| Q4 2022 | $476,377,910 | -22.8% | 9,212,491 | +2.0% | 0.01% | -27.8% |
| Q3 2022 | $616,823,000 | +56.3% | 9,031,079 | +3.5% | 0.02% | +63.6% |
| Q2 2022 | $394,623,000 | -9.4% | 8,726,745 | +1.8% | 0.01% | +10.0% |
| Q1 2022 | $435,400,000 | +16.3% | 8,569,170 | +8.2% | 0.01% | +25.0% |
| Q4 2021 | $374,320,000 | +68.2% | 7,917,099 | +17.3% | 0.01% | +33.3% |
| Q3 2021 | $222,555,000 | -44.5% | 6,752,285 | +6.4% | 0.01% | -40.0% |
| Q2 2021 | $400,969,000 | +53.1% | 6,344,456 | +3.9% | 0.01% | +42.9% |
| Q1 2021 | $261,945,000 | -17.4% | 6,104,517 | +10.2% | 0.01% | -22.2% |
| Q4 2020 | $316,992,000 | +143.3% | 5,541,825 | +28.3% | 0.01% | +125.0% |
| Q3 2020 | $130,285,000 | -9.1% | 4,318,357 | -1.6% | 0.00% | -20.0% |
| Q2 2020 | $143,318,000 | +76.4% | 4,388,181 | +44.7% | 0.01% | +66.7% |
| Q1 2020 | $81,267,000 | +9.9% | 3,033,471 | +25.6% | 0.00% | 0.0% |
| Q4 2019 | $73,926,000 | +42.3% | 2,414,314 | +11.9% | 0.00% | +50.0% |
| Q3 2019 | $51,965,000 | -0.0% | 2,157,086 | +5.2% | 0.00% | 0.0% |
| Q2 2019 | $51,968,000 | +33.0% | 2,050,838 | +2.4% | 0.00% | 0.0% |
| Q1 2019 | $39,064,000 | +105.7% | 2,003,283 | +39.1% | 0.00% | +100.0% |
| Q4 2018 | $18,994,000 | -24.5% | 1,440,038 | +1.8% | 0.00% | 0.0% |
| Q3 2018 | $25,157,000 | -14.8% | 1,414,900 | +5.4% | 0.00% | 0.0% |
| Q2 2018 | $29,530,000 | +249.0% | 1,342,290 | +250.8% | 0.00% | – |
| Q1 2018 | $8,461,000 | +42.3% | 382,653 | +39.6% | 0.00% | – |
| Q4 2017 | $5,947,000 | – | 274,074 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |